This article focuses on DSCSA from an operational execution perspective, how interoperability behaves inside daily warehouse, quality, and supply chain workflows.
Blog
Whitepaper: NDC12 – Revising the National Drug Code Format and Drug Label Barcode Requirements for the U.S. Market
This white paper blends the original high-level summary with a more detailed narrative, offering both clear structure and practical depth. It explains the new NDC format, explores stakeholder impacts, describes the implications for GTIN, and outlines concrete next steps and emerging solution options.
Hyperautomation Hits Pharma: Merging RPA and AI for End-to-End Supply Chain Efficiency
This blog post will explore the power of hyperautomation, its most impactful applications, and the strategic guidance needed to navigate the inevitable workforce and cultural shifts, highlighting quick wins that many competitors overlook.
Reshoring and Nearshoring: Rebuilding Pharma Supply Chains for Localization and Resilience
For decades, the global pharmaceutical industry operated on a model of maximum efficiency, often driven by the pursuit of the lowest cost. This led to a highly complex, geographically dispersed pharma supply chain, with raw material suppliers, API (Active Pharmaceutical Ingredient) manufacturers, and drug packagers often located thousands of miles...
On-Demand Pharma: Adapting Supply Chains for Personalized Medicine and Small-Batch Production
Personalized medicine, or precision medicine, is a fundamental change in how we treat disease. Instead of a single drug for a broad population, these therapies are designed for a patient's unique biological and genetic profile.
